Table 1. Characteristics of the patients (n=107).
| Characteristic | Median (quartile) or frequency |
|---|---|
| Gender (male/female) | 84/23 |
| Age (years) | 63.0 (58.5, 68.0) |
| Smoking (yes/no) | 94/13 |
| CEA (ng/mL) | 15.43 (5.03, 63.87) |
| NSE (ng/mL) | 24.10 (12.55, 58.13) |
| D-dimer (mg/L) | 0.59 (0.33, 1.10) |
| Haemoglobin (g/L) | 116 (108.0, 124.0) |
| Albumin (g/L) | 35 (32.0, 39.0) |
| ECOG-PS [0/1/2/3/4] | 45/37/19/5/1 |
| Stage (extensive/limited) | 65/42 |
| Treatment approach | |
| Chemotherapy | 25 |
| Chemotherapy and radiotherapy | 82 |
| Follow up time (months) | 9 (6.0, 16.0) |
| Outcomes (dead/alive) | 91/16 |
Skewed distribution continuous data are expressed as the median and quartiles. CEA, carcinoembryonic antigen; ECOG-PS, Eastern Cooperative Oncology Group performance status; NSE, neuron-specific enolase.